MAXCYTE, INC.
MAXCYTE, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 15 | 15 | 20 | 13 | 15 | 23 | 28 | 37 | 38 | 22 | 47 | 49 | |||||
Short Term Investments | 91 | 92 | 83 | 93 | 111 | 115 | 127 | 117 | 120 | 135 | 122 | 141 | |||||
Accounts Receivable Net Current | 4 | 4 | 4 | 8 | 6 | 6 | 5 | 5 | 5 | 6 | 6 | 8 | |||||
Inventory Net | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 | 12 | 12 | 13 | |||||
Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 3 | |||||
Assets Current | 121 | 123 | 118 | 125 | 143 | 156 | 172 | 173 | 176 | 179 | 190 | 214 | |||||
Long Term Investments | 36 | 41 | 53 | 52 | 39 | 36 | 36 | 43 | 42 | 45 | 43 | 18 | |||||
Property Plant And Equipment Net | 15 | 17 | 18 | 19 | 19 | 20 | 20 | 21 | 22 | 23 | 24 | 24 | |||||
Operating Lease Right Of Use Asset | 10 | 11 | 11 | 11 | 11 | 12 | 11 | 11 | 11 | 11 | 11 | 10 | |||||
Goodwill | - | - | - | 4 | 4 | 4 | - | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 0 | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 1 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | |||||
Assets | 185 | 194 | 203 | 213 | 220 | 230 | 239 | 249 | 251 | 258 | 268 | 267 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 0 | |||||
Accrued Liabilities And Other Liabilities | 4 | 4 | 8 | 8 | 6 | 5 | 8 | 8 | 7 | 7 | 11 | 10 | |||||
Operating Lease Liability Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Revenue Current | 2 | 3 | 4 | 5 | 3 | 4 | 5 | 7 | 3 | 4 | 5 | 6 | |||||
Liabilities Current | 10 | 10 | 14 | 16 | 12 | 13 | 16 | 18 | 12 | 13 | 18 | 17 | |||||
Operating Lease Liability Noncurrent | 16 | 16 | 16 | 17 | 17 | 18 | 17 | 17 | 18 | 18 | 18 | 15 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Liabilities | 26 | 27 | 31 | 33 | 29 | 31 | 33 | 35 | 30 | 32 | 36 | 33 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital | 434 | 433 | 432 | 431 | 429 | 425 | 422 | 419 | 415 | 411 | 407 | 403 | |||||
Retained Earnings Accumulated Deficit | -275 | -266 | -261 | -252 | -239 | -227 | -217 | -206 | -195 | -185 | -176 | -171 | |||||
Stockholders Equity | 159 | 168 | 171 | 180 | 191 | 199 | 206 | 213 | 221 | 226 | 232 | 233 | |||||
Liabilities And Stockholders Equity | 185 | 194 | 203 | 213 | 220 | 230 | 239 | 249 | 251 | 258 | 268 | 267 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | |||||
Common Stock Shares Issued | 107 | 107 | 107 | 107 | 107 | 106 | 106 | 105 | 105 | 104 | 104 | 104 | |||||
Shares Outstanding | 106 | 107 | 107 | 107 | 107 | 106 | 106 | 105 | 105 | 104 | 104 | 104 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.76% | 19.12% | 2.94% | - | - | - | - | - | - | - | - | - |
| 2025 | -2.06% | -9.47% | -7.41% | -31.86% | -25.00% | -20.10% | -2.65% | 2.65% | -39.93% | 22.90% | 50.72% | 62.32% |
| 2024 | 13.99% | -0.25% | 21.88% | -2.92% | -13.03% | -19.78% | -8.51% | 6.44% | 20.10% | -29.39% | -18.73% | -31.41% |
| 2023 | - | - | - | - | - | - | 48.66% | 40.30% | 50.15% | 4.27% | -5.28% | 12.56% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 12.26 | 12.04 | 8.30 | 7.74 | 12.39 | 12.23 | 10.88 | 9.81 | 14.31 | 13.26 | 10.65 | 12.87 | |||||
| Quick Ratio | 11.10 | 10.88 | 7.47 | 7.08 | 11.45 | 11.29 | 10.09 | 8.99 | 13.19 | 12.13 | 9.75 | 11.92 | |||||
| Working Capital | 111.38M | 112.73M | 104.10M | 108.54M | 131.66M | 143.02M | 155.91M | 155.29M | 163.37M | 165.20M | 172.34M | 197.69M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.16 | 0.16 | 0.18 | 0.18 | 0.15 | 0.15 | 0.16 | 0.17 | 0.14 | 0.14 | 0.16 | 0.14 | |||||
| Debt Ratio | 0.14 | 0.14 | 0.15 | 0.16 | 0.13 | 0.13 | 0.14 | 0.14 | 0.12 | 0.12 | 0.13 | 0.13 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | |||||
| Days Sales Outstanding TTM | 56.86 | 55.23 | 45.23 | 68.22 | 52.75 | 55.78 | 49.42 | 50.93 | 48.95 | 59.18 | 74.94 | 74.83 | |||||
| Receivables Turnover TTM | 6.42 | 6.61 | 8.07 | 5.35 | 6.92 | 6.54 | 7.39 | 7.17 | 7.46 | 6.17 | 4.87 | 4.88 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.33 | -0.37 | -0.42 | -0.43 | -0.42 | -0.39 | -0.39 | -0.34 | -0.34 | -0.35 | -0.37 | -0.36 | |||||
| Free Cash Flow Per Share TTM | -0.29 | -0.28 | -0.34 | -0.25 | -0.22 | -0.31 | -0.28 | -0.20 | -0.24 | -0.30 | -0.25 | -0.33 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 79.23% | 80.51% | 81.16% | 79.97% | 79.79% | 80.91% | 81.62% | 85.98% | 88.43% | 88.32% | 88.51% | 87.61% | |||||
| Operating Profit Margin TTM | -134.59% | -141.81% | -157.14% | -155.65% | -149.57% | -135.94% | -132.54% | -101.74% | -101.87% | -107.59% | -116.98% | -123.41% | |||||
| Net Profit Margin TTM | -114.77% | -121.16% | -135.14% | -132.58% | -125.23% | -110.92% | -106.29% | -78.37% | -77.97% | -83.00% | -91.85% | -98.45% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -13.15% | -14.30% | -14.50% | -24.52% | -21.32% | -14.48% | -6.44% | 19.85% | 11.69% | 6.80% | -6.72% | -21.53% | |||||
| Net Income Growth (1Y) | -20.41% | -6.39% | 8.71% | 27.69% | 26.37% | 14.28% | 8.26% | -4.59% | 8.56% | 20.34% | 60.89% | 21.84% | |||||
| EPS Growth (1Y) | -20.72% | -7.20% | 7.10% | 25.89% | 24.27% | 12.28% | 6.63% | -6.10% | 6.92% | 18.90% | 58.45% | 19.90% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -3.69 | -1.92 | -3.70 | -3.69 | -5.18 | -6.92 | -10.62 | -11.44 | -11.58 | -11.93 | -12.80 | -8.62 | |||||
| P/B TTM | 0.83 | 0.45 | 0.96 | 0.93 | 1.22 | 1.45 | 2.11 | 1.92 | 1.85 | 1.93 | 2.09 | 1.38 | |||||
| P/S TTM | 4.23 | 2.33 | 4.99 | 4.89 | 6.49 | 7.68 | 11.29 | 8.97 | 9.03 | 9.90 | 11.76 | 8.48 | |||||
| Market Cap | 131.39M | 75.13M | 164.96M | 168.45M | 231.96M | 289.24M | 436.17M | 408.88M | 410.19M | 436.14M | 485.36M | 322.76M | |||||
| Enterprise Value | 116.35M | 60.58M | 144.90M | 155.48M | 216.73M | 265.86M | 408.29M | 371.92M | 372.67M | 413.89M | 438.86M | 273.59M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -30.49M | -29.49M | -36.32M | -26.30M | -23.34M | -32.96M | -29.26M | -21.23M | -25.39M | -30.87M | -25.39M | -33.73M | |||||
| Net Debt | -15.04M | -14.56M | -20.07M | -12.97M | -15.23M | -23.39M | -27.88M | -36.96M | -37.51M | -22.25M | -46.51M | -49.17M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MAXCYTE, INC. (MXCT) — SEC Financial Statements & Analysis
MAXCYTE, INC. (MXCT) is a services-commercial physical & biological research company, incorporated in DE. MAXCYTE, INC. trades on Nasdaq as: MXCT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MAXCYTE, INC. reported a -13.15% year-over-year revenue growth, a Gross Profit Margin of 79.23% (TTM), a Debt-to-Equity ratio of 0.16x, a Price-to-Sales (P/S) ratio of 4.23x (TTM), a Price-to-Book (P/B) ratio of 0.83x (TTM), at a market cap of $131.39M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -13.15%
- Gross Profit Margin TTM
- 79.23%
- Debt To Equity
- 0.16x
- P/S TTM
- 4.23x
- P/B TTM
- 0.83x
- Market Cap
- $131.39M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MAXCYTE, INC. in?
MAXCYTE, INC. (MXCT) operates in the Services-Commercial Physical & Biological Research industry.
What is MXCT's market cap?
MAXCYTE, INC. (MXCT) has a market capitalization of $131.39M as of 2026-06-30.
What exchange does MXCT trade on?
MAXCYTE, INC. (MXCT) trades on the Nasdaq.
Where is MAXCYTE, INC. incorporated?
MAXCYTE, INC. is incorporated in DE.